Skip to main content
SpringerLink
Log in

Study of the in vitro bioactivation of albendazole in human liver microsomes and hepatoma cell lines

  • Published:
Cell Biology and Toxicology Aims and scope Submit manuscript

Abstract

The metabolism of albendazole (ABZ), a benzimidazole anthelminthic, was studied in either microsomal preparations of human liver biopsies or cultured human hepatoma cell lines. Metabolites were analyzed by HPLC. Our data show that microsomes from human biopsies and two human cell lines, HepG2 and Hep3B, oxidize the drug to the sulfoxide very efficiently, whereas the third cell line tested, SK-HEP-1, does not. Both cytochrome P-450 dependent monooxygenases and favin-containing monooxygenases appear to be involved in human ABZ metabolism. Using the cell line displaying the highest ABZ-metabolizing activity, HepG2, the cytotoxic and the inducing effects of the parent drug ABZ and of two primary metabolites, the sulfoxide and the sulfone were studied. These three chemicals provoked a rise in mitotic index resulting from cell division blockage at the prophase or at the metaphase (ABZ metabolites) stage, and ABZ was more cytotoxic than its metabolites. With regard to enzyme-inducing effects, our data clearly demonstrate that the sulfoxide and, to a lesser degree, the sulfone are potent inducers of some drug metabolizing enzymes (i.e., cytochrome P-488 dependent monooxygenases and UDP glucuronyltransferase), whereas ABZ fails to increase and even slightly decreases these enzymatic activities. In conclusion, the HepG2 human hepatoma cell line appears to be suitable for the study of many parameters of metabolism and action of ABZ and other structurally related compounds in humans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ABZ:

albendazole

B[a]P:

benzo[a]pyrene

HPLC:

high-performance liquid chromatography

MC:

3-methylcholanthrene

MFO:

mixed-function oxidase

UDPGT:

UDP-glucuronyltransferase

References

  • ADEN, D.P., FOGEL, A., PLOTKIN, S.A., DAMJANOV, I. and KNOWLES, B.B. (1979). Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282:615–616.

    Google Scholar 

  • ASTROM, A., MANER, S. and DEPIERRE, J.W. (1987). Induction of liver microsomal epoxide hydrolase, UDP-glucuronyltransferase and cytosolic glutathione transferase in different rodent species by 2-acetylaminofluorene or 3-methylcholanthrene. Xenobiotica 17:155–163.

    Google Scholar 

  • BARROWMAN, M.M., MARRINER, S.E. and BOGAN, J.A. (1984). The binding and subsequent inhibition of tubulin polymerisation in ascaris suum (in vitro) by benzimidazole anthelmintics. Biochem. Pharmacol. 33:3037–3040.

    Google Scholar 

  • BARTSCH, H., KUROKI, T., ROBERFROID, M. and MALAVEILLE, C. (1982). Metabolic Activation System in vitro for Carcinogen/Mutagen Screening Tests. Chemical Mutagens 7:95–161.

    Google Scholar 

  • BAST, A., SAVENIJE-CHAPEL, E.M. and KROES, B.H. (1984). Inhibition of monoxygenase and oxidase activity of rat hepatic cytochrome P-450 by H2 receptor blockers. Xenobiotica 14:399–408.

    Google Scholar 

  • BURKE, M.D. and MAYER, R.T. (1974). Ethoxyresorufin: Direct fluometric assay of a microsomal O-dealkylation, which is preferentially induced by 3-methylcholenthrene. Drug Metab. Dispos. 2:583–588.

    Google Scholar 

  • COMER, P., CHENGELIS, C.P., LEVIN, S. and KOTSONIS, F.N. (1985). Changes in thyroidal function and liver UDP glucuronyltransferase activity in rats following administration of a novel imidazole (SC37211). Toxicol. Appl. Pharmacol. 80:427–436.

    Google Scholar 

  • DAVIS, A., PAWLOSKI, Z.S. and DIXON, H. (1986). Multicentre clinical trials of benzimidazolecarbamates in human echinococcosis. WHO Bulletin 64:383–388.

    Google Scholar 

  • DAWSON, J.R., ADAMS, D.J. and WOLF, C.R. (1985). Induction of drug metabolizing enzymes in human liver cell line HepG2. FEBS Letters 183:219–222.

    Google Scholar 

  • DEARFIELD, K.L., JACOBSON-KRAM, D., BROWN, N.A. and WILLIAMS, J.R. (1983). Evaluation of a human hepatoma cell line as a target cell in genetic toxicology. Mutat. Res. 108:437–449.

    Google Scholar 

  • DECAD, G.M., HSIEH, D.P. and BYARD, J.L. (1977). Maintenance of cytochrome P-450 and metabolism of aflatoxin B1 in primary hepatocyte cultures. Biochem. Biophys. Res. Commun. 78:279–287.

    Google Scholar 

  • DELATOUR, P., PARISH, R. and GYURIK, R.J. (1981). Albendazole: a comparison of relay embryotoxicity with embryotoxicity of individual metabolites. Am. Rech. Vet. 12:159–167.

    Google Scholar 

  • DELATOUR, P., GARNIER, F., BENOIT, E. and LONGIN, C. (1984). A correlation of toxicity of albendazole and of oxfendazole with their free metabolites and bound residues. J. Vet. Pharmacol. Ther. 7:139–145.

    Google Scholar 

  • DELATOUR, P. and PARISH, R. (1986). Benzimidazole anthelmintics and related compounds: Toxicity and evaluation of residues. Adv. Vet. Sci. Comp. Med. 31:175–204.

    Google Scholar 

  • DIAMOND, L., KRUSZEWSKI, F., ADEN, D.P., KNOWLES, B.B. and BAIRD, W.M. (1980). Metabolic activation of benzo[a]pyrene by a human hepatoma cell line. Carcinogenesis 1:871–875.

    Google Scholar 

  • DICKSON, B. (1983). Summary of albendazole clinical trials in Middle East and Africa. In: Albendazole in Helminthiasis. pp. 79–85. (International Congress and Symposium, Series 61). The Royal Society of Medicine, London.

    Google Scholar 

  • DOUCH, P.G. and BUCHANAN, L.L. (1979). Some properties of sulfoxidases and sulfoxide reductases of the cestode Monieza expansa, the nematode Ascaris suum and mouse liver. Xenobiotica 9:675–679.

    Google Scholar 

  • DRAGACCI, S., THOMASSIN, J., MAGDALOU, J., SOUHAILI-EL AMRI, H., BOISSEL, P. and SIEST, G. (1987). Properties of human hepatic UDP-glucuronyltransferases. Relationship to other inducible enzymes in patients with cholestasis. Eur. J. Clin. Pharmacol. 32:485–491.

    Google Scholar 

  • FARGETTON X., GALTIER, P. and DELATOUR, P. (1986). Sulfoxidation of albendazole by a cytochrome P-450-independent monooxygenase from rat liver microsomes. Vet. Res. Commun. 10:317–324.

    Google Scholar 

  • FOGH, J. and TREMPE, G. (1975). New human tumor cell lines. In: Fogh J. (ed). Human tumor cells in vitro. Plenum Press, New York, pp. 115–159.

    Google Scholar 

  • GALTIER, P., ALVINERIE, M. and DELATOUR, P. (1986). In vitro sulfoxidation of albendazole by ovine liver microsomes: Assay and frequency of various xenobiotics. Am. J. Vet. Res. 47:447–452.

    Google Scholar 

  • GHERSI-EGEA, J.F., WALTHER B., DECOLIN, D., MINN, A. and SIEST, G. (1987). The activity of 1-naphtol-UDP-glucuronyltransferase in the brain. Neuropharmacology 26:367–372.

    Google Scholar 

  • GYURIK, R.J., CHOW, A.W., ZABER, B., BRUNER, E.L., MILLER, J.A., VILLANI, A.J., PETKA, L.A. and PARISH, R. (1981). Metabolism of albendazole in cattle, sheep, rats and mice. Drug Metab. Dispos. 9:503–508.

    Google Scholar 

  • HANIGAN, M.H. and PITOT, H.C. (1985). Gamma-glutamyltranspeptidase. Its role in hepatocarcinogenesis. Carcinogenesis 6:165–172.

    Google Scholar 

  • HOLDER, G.M., LITTLE, P.J., RYAN, A.J. and WATSON, T.R. (1976). Inhibitors of hepatic mixed function oxidases. II. Some benzimidazole, benzoxazole and benzothiazole derivatives. Biochem. Pharmacol. 25:2747–2750.

    Google Scholar 

  • HUBERMAN, E. and SACHS, L. (1974). Cell-mediated mutagenesis of mammalian cells with chemical carcinogens. Int. J. Cancer 13:326–333.

    Google Scholar 

  • IRELAND, C.M., GULL, K., GUTTERIDGE, W.E. and POGSON, C.I. (1979). The interaction of benzimidazole carbamates with mammalian microtubule protein. Biochem. Pharmacol. 28:2680–2682.

    Google Scholar 

  • JEFCOATE, C.R., GAYLOR, G.L. and CALABRESE, R.L. (1980). Ligand interaction with cytochrome P-450. I. Binding of primary amine. Biochemistry 8:3455–3463.

    Google Scholar 

  • JENSEN, J.C. and GUGLER, R. (1986). Inhibition of human liver cytochrome P-450 by omeprazoler. Br. J. Clin. Pharm. 21:328–330.

    Google Scholar 

  • KOOP, D.R., CRUMP, B.L., NORDBLOM, G.D. and COON, M.J. (1985). Immunochemical evidence for induction of the alcohol oxidizing cytochrome P-450 of rabbit liver microsomes by diverse agents ethanol, imidazole, trichloroethylene, acetone, pyrazole and isoniazid. Proc. Natl. Acad. Sci. 82:4065–4069.

    Google Scholar 

  • LIMBOSCH, S. (1983). Benzo(a)pyrene- and aldrin-metabolizing activities in cultured human and rat hepatoma cell lines. J. Natl. Cancer Inst. 71:281–286.

    Google Scholar 

  • LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. and RANDALL, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275.

    Google Scholar 

  • MARRINER, S.E. and BOGAN, J.A. (1980). Pharmacokinetics of albendazole in sheep. Am. J. Vet. Res. 41:1126–1129.

    Google Scholar 

  • MARRINER, S.E., MORRIS, D.L., DICKSON, B. and BOGAN, J.A. (1986). Pharmacokinetics of albendazole in man. Eur. J. Pharmacol. 30:705–708.

    Google Scholar 

  • OWENS, I.S. (1977). Genetic regulation of UDP-glucuronyltransferase induction by polycyclic aromatic compounds in mice. J. Biol. Chem. 252:2827–2833.

    Google Scholar 

  • PENICAULT, B., MAUGEIN, P.H., MAISONNEUVE, H. and ROSSIGNOL, J.F. (1983). Pharmacocinetique et metabolisme urinaire de l'albendazole chez l'homme. Bull. Soc. Path. Ex. 76:698–708.

    Google Scholar 

  • PRICHARD, R.K., HENESSY, D.R., STEEL, J.N. and LACEY, E. (1985). Metabolite concentrations in plasma following treatment of cattle with five anthelmintics. Res. Vet. Sci. 39:173–178.

    Google Scholar 

  • RENDIC, S., RUF, H.H., WEBER, P. and KAJFEZ, F. (1984). Cimetidine and ranitidine: their interaction with human liver microsomes and with purified cytochrome P-450. European J. Drug Metab. Pharmacokin. 9:195–200.

    Google Scholar 

  • RICHARDS, W.L., TSUKODA, Y. and VAN POTTER, R. (1982). Phenotypic diversity of glutamyltranspeptidase activity and protein secretion in hepatoma cell lines. Cancer Res. 42:1374–1383.

    Google Scholar 

  • ROSSIGNOL, J.F. (1983). Double blind placebo-controlled clinical trials of albendazole: World Summary. In: Albendazole in Helminthiasis, pp. 79–85. (International Congress and Symposium, Series 61). The Royal Society of Medicine, London.

    Google Scholar 

  • SAIMOT, A.G., CREMIEUX, A.C., HAY, L.M., MEULEMANS A., GIOVANANGELI, M.D., DELAITRE, B. and COULAUD, J.P. (1983). Albendazole as a potential treatment for human hydatidosis. The Lancet 17:652–656.

    Google Scholar 

  • SASSA, S., SUGITA, O., GALBRAITH, R.A. and KAPPAS, A. (1987). Drug metabolism by the human hepatoma cell, HepG2. Biochem. Biophys. Res. Comm. 143:52–57.

    Google Scholar 

  • SIEST, G., BAGREL, D., LEVY, M., FEBVRE, N., FOURNEL-GIGLEUX, S., ROLIN, S., SABOLOVIC, N., WELLMAN, M., GALTEAU, M.M. and TOYODA, Y. (1988). The use of hepatoma cells in culture as an alternative for study of drug metabolizing enzymes. In: Metabolism of Xenobiotics (J.W. Gorrod, H. Oelschlager and J. Caldwell, eds.), pp. 285–293. Taylor and Francis, London-New York-Philadelphia.

    Google Scholar 

  • SOUHAILI-EL AMRI, H., FARGETTON, X., DELATOUR, P. and BATT, A.M. (1987). Sulphoxidation of albendazole by the FAD-containing and cytochrome P-450 dependent monooxygenases from pig liver microsomes. Xenobiotica 17:1159–1168.

    Google Scholar 

  • SOUHAILI-EL AMRI, H., FARGETTON, X., BENOIT, E., TOTIS, M. and BATT, A.M. (1988). Inducing effect of albendazole on rat liver drug metabolizing enzymes and metabolite pharmacokinetics. Toxicol. Appl. Pharmacol. 92:141–149.

    Google Scholar 

  • SZASZ, G. (1969). A kinetic photometric method for serum gamma-glutamyltranspeptidase. Clin. Chem. 19:124–126.

    Google Scholar 

  • THEODORIDES, V.J., GYURIK, R.J., KINGSBURY, W.D. and PARISH, R.C. (1976). Anthelmintic activity of albendazole against liver flukes, tapeworms, lung and gastrointestinal roundworms. Experientia 32:702–703.

    Google Scholar 

  • ZIEGLER, D.M. (1980). Microsomal flavin containing monooxygenase, oxygenation of nucleophilic nitrogen and sulfur containing compounds. In: Enzymatic Basis of Detoxification. W. B. Jakoby, ed., pp. 201–227. Academic Press, New York.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dártement de Biologie Moléculaire, Universite Libre de Bruxelles, Rhode-St-Genèse, Belgium

    Sylvie Rolin

  2. Centre du Médicament, U.A. C.N.R.S., 597, Nancy, France

    Hajar Souhaili-El Amri, Anne-Marie Batt, Michele Levy, Denyse Bagrel & Gerard Siest

Authors
  1. Sylvie Rolin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hajar Souhaili-El Amri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anne-Marie Batt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michele Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Denyse Bagrel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gerard Siest
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rolin, S., Amri, H.SE., Batt, AM. et al. Study of the in vitro bioactivation of albendazole in human liver microsomes and hepatoma cell lines. Cell Biol Toxicol 5, 1–14 (1989). https://doi.org/10.1007/BF00141060

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00141060

Key words

Search

Navigation